Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats

Adamek, 1984, The indusium griseum in the mouse: architecture, Timm's histochemistry and some afferent connections, Brain Res. Bull., 12, 657, 10.1016/0361-9230(84)90147-3

Aguado-Llera, 2007, 17Beta-estradiol protects depletion of rat temporal cortex somatostatinergic system by beta-amyloid, Neurobiol. Aging, 28, 1396, 10.1016/j.neurobiolaging.2006.06.009

Ahmed, 1995, Afferent projections to the cingulate cortex in albino rats: a study with a retrograde labeling method using fluoro-gold, Kobe J. Med. Sci., 41, 247

Amaral, 2007, The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies), Prog. Brain Res., 163, 3, 10.1016/S0079-6123(07)63001-5

Anderson, 1995, Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors, J. Comp. Neurol., 357, 296, 10.1002/cne.903570209

Arancibia, 1987, La technique de perfusion “push-pull” en Neuroendocrinologie, Ann. Endocrinol. (Paris), 48, 410

Arancibia, 2001, Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus, Hippocampus, 11, 469, 10.1002/hipo.1061

Arancibia, 2007, In vivo BDNF release and TrkB receptors expression in the supraoptic nucleus after osmotic stress stimulus in rats, Neuroscience, 146, 864, 10.1016/j.neuroscience.2007.01.057

Arvanitis, 2007, High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB, J. Neurochem., 10.1111/j.1471-4159.2007.04704.x

Blake, 2004, Delineating somatostatin's neuronal actions, Curr. Drug Targets CNS Neurol. Disord., 3, 153, 10.2174/1568007043482534

Brewer, 1993, Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination, J. Neurosci. Res., 35, 567, 10.1002/jnr.490350513

Canossa, 1997, Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity, Proc. Natl. Acad. Sci. U. S. A., 94, 13279, 10.1073/pnas.94.24.13279

Chan-Palay, 1987, Somatostatin immunoreactuve neurons in the human hippocampus and cortex shown by immuno-gold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia, J. Comp. Neurol., 260, 201, 10.1002/cne.902600205

Choi, 2007, Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase, J. Neurosci., 27, 2999, 10.1523/JNEUROSCI.4913-06.2007

Dournaud, 1994, Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex, Neuroscience, 61, 755, 10.1016/0306-4522(94)90399-9

Echeverria, 2007, Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical, Nerurons. Curr. Alzheimer Res., 4, 518, 10.2174/156720507783018190

Farber, 1982, Biology of disease: membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis, Lab. Invest., 47, 114

Garcia, 1995, Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex, Stroke, 26, 636, 10.1161/01.STR.26.4.636

Geci, 2007, Beta-amyloid increases somatostatin expression in cultured cortical neurons, J. Neurochem., 101, 664, 10.1111/j.1471-4159.2006.04415.x

Giovannelli, 1998, Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain, Neuroscience, 87, 349, 10.1016/S0306-4522(98)00169-9

Givalois, 2004, Expression of BDNF and its receptors in the median eminence cells with sensitivity to stress, Endocrinology, 135, 4737, 10.1210/en.2004-0616

Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4

Gruden, 2007, Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to Ab (25–35) oligomers, S100b and neurotransmitters, J. Neuroimmunol., 186, 181, 10.1016/j.jneuroim.2007.03.023

Hama, 2005, Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide, Med. Hypotheses, 65, 498, 10.1016/j.mehy.2005.02.045

Hampel, 2002, J. Neural Transm., 109, 837, 10.1007/s007020200069

Holsinger, 2000, Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease, Mol. Brain Res., 76, 347, 10.1016/S0169-328X(00)00023-1

Ivins, 1999, Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8, Neurobiol. Dis., 6, 440, 10.1006/nbdi.1999.0268

Knusel, 1992, Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain, J. Neurosci., 12, 4391, 10.1523/JNEUROSCI.12-11-04391.1992

Koizumi, 1988, K-252a: a specific inhibitor of the action of nerve growth factor on PC12 cells, J. Neurosci., 8, 715, 10.1523/JNEUROSCI.08-02-00715.1988

Kubo, 2002, In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1–40) to truncated and toxic fragments ([D-Ser 26]A beta 25–35/40) and fragment presence in the brains of Alzheimer's patients, J. Neurosci. Res., 70, 474, 10.1002/jnr.10391

Kunzle, 2004, The hippocampal continuation (indusium griseum): its connectivity in the hedgehog tenrec and its status within the hippocampal formation of higher vertebrates, Anat. Embryol. (Berl.), 208, 183, 10.1007/s00429-004-0384-3

Laske, 2007, BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls, J. Psychiat. Res., 41, 387, 10.1016/j.jpsychires.2006.01.014

Lewin, 1996, Physiology of the neurotrophins, Annu. Rev. Neurosci., 19, 289, 10.1146/annurev.ne.19.030196.001445

Lindvall, 1994, Neurotrophins and brain insults, Trends Neurosci., 17, 490, 10.1016/0166-2236(94)90139-2

Lowenstein, 1992, Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus, J. Neurosci., 12, 4846, 10.1523/JNEUROSCI.12-12-04846.1992

Manthorpe, 1986, An automated colorimetric microassay for neuronotrophic factors, Brain Res., 390, 191, 10.1016/0165-3806(86)90208-7

Mattson, 1995, Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem., 65, 1740, 10.1046/j.1471-4159.1995.65041740.x

Maurice, 1996, Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction, Brain Res., 706, 181, 10.1016/0006-8993(95)01032-7

McAllister, 1999, Neurotrophins and synaptic plasticity, Annu. Rev. Neurosci., 22, 295, 10.1146/annurev.neuro.22.1.295

Merlio, 1992, Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system, Neuroscience, 51, 513, 10.1016/0306-4522(92)90292-A

Meunier, 2006, The anti-amnesic and neuroprotective effects of donepezil against amyloid beta(25–35) peptide-induced toxicity in mice involve an interaction with the sigma(1) receptor, Br. J. Pharmacol., 149, 998, 10.1038/sj.bjp.0706927

Michalski, 2003, Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease, Mol. Brain Res., 111, 148, 10.1016/S0169-328X(03)00003-2

Mufson, 1996, Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons, Neuroscience, 71, 179, 10.1016/0306-4522(95)00431-9

Murer, 1999, An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease, Neuroscience, 88, 1015, 10.1016/S0306-4522(98)00219-X

Ohm, 2007, The dentate gyrus in Alzheimer's disease, Prog. Brain Res., 163, 723, 10.1016/S0079-6123(07)63039-8

Olivieri, 2003, Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin, Neuroscience, 120, 659, 10.1016/S0306-4522(03)00342-7

Paxinos, 1997

Peng, 2005, Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease, J. Neurochem., 93, 1412, 10.1111/j.1471-4159.2005.03135.x

Perry, 2004, Antioxidants are required during the early critical period, but not later, for neuronal survival, J. Neurosci. Res., 78, 485, 10.1002/jnr.20272

Phillips, 1991, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron, 7, 695, 10.1016/0896-6273(91)90273-3

Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993

Pike, 1995, Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25–35 region to aggregation and neurotoxicity, J. Neurochem., 64, 253, 10.1046/j.1471-4159.1995.64010253.x

Poo, 2001, Neurotrophins as synaptic modulators, Nature Rev. Neurosci., 2, 24, 10.1038/35049004

Ramos, 2006, Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease, Neurobiol. Aging, 27, 1658, 10.1016/j.neurobiolaging.2005.09.022

Rozen, 2000, Primer3 on the WWW for general users and for biologist programmers, Methods Mol. Biol., 132, 365

Saito, 2005, Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation, Nat. Med., 11, 434, 10.1038/nm1206

Schwartz, 1998, Somatostatin as a neurotrophic factor—which receptor/second messenger transduction system is involved?, Perspect. Develop. Neurobiol., 5, 427

Sigurdsson, 1997, Bilateral injections of amyloid-beta 25–35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects, Neurobiol. Aging, 18, 591, 10.1016/S0197-4580(97)00154-1

Silhol, 2007, Spatial memory training modifies the expression of brain-derived neurotrophic factor tyrosine kinase receptors in young and aged rats, Neuroscience, 146, 962, 10.1016/j.neuroscience.2007.02.013

Skaper, 1998, Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway, J. Neurochem., 70, 1859, 10.1046/j.1471-4159.1998.70051859.x

Stepanichev, 2000, Neurochemical, behavioural and neuromorphological effects of central administration of b-amyloid peptide (25–35) in rat, Neurochemistry [Nejrokhimija Rus], 17, 291

Stepanichev, 2004, Amyloid-beta (25–35)-induced memory impairments correlate with cell loss in rat hippocampus, Physiol. Behav., 80, 647, 10.1016/j.physbeh.2003.11.003

Tallent, 2007, Somatostatin in the dentate gyrus, Prog. Brain Res., 163, 265, 10.1016/S0079-6123(07)63016-7

Tanaka, 1997, Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus, J. Neurosci., 17, 2959, 10.1523/JNEUROSCI.17-09-02959.1997

Tapia-Arancibia, 1989, Actions of excitatory amino acids on somatostatin release from cortical neurons in primary cultures, J. Neurochem., 53, 1134, 10.1111/j.1471-4159.1989.tb07406.x

Tapia-Arancibia, 2004, Physiology of BDNF: focus on hypothalamic function, Front. Neuroendocrinol., 25, 77, 10.1016/j.yfrne.2004.04.001

Teipel, 1998, Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease, Neurology, 51, 1381, 10.1212/WNL.51.5.1381

Teipel, 2003, Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration, Neurobiol. Aging, 24, 85, 10.1016/S0197-4580(02)00044-1

Thoenen, 1995, Neurotrophins and neuronal plasticity, Science, 270, 593, 10.1126/science.270.5236.593

Tong, 2004, Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons, J. Neurosci., 24, 6799, 10.1523/JNEUROSCI.5463-03.2004

Vecsei, 1995, Somatostatin and Alzheimer's disease, Arch. Gerontol. Geriatr., 21, 35, 10.1016/0167-4943(95)00640-7

Wang, 2006, Amyloid-[beta] at sublethal level impairs BDNF-induced arc expression in cortical neurons, Neurosci. Lett., 398, 78, 10.1016/j.neulet.2005.12.057

Wiltshire, 2005, Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease, Dement. Geriatr. Cogn. Disord., 20, 345, 10.1159/000088526

Wyss, 1983, The indusium griseum and anterior hippocampal continuation in the rat, J. Comp. Neurol., 219, 251, 10.1002/cne.902190302

Yamauchi, 2000, Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 69, 623, 10.1136/jnnp.69.5.623

Yan, 1994, Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression, Exp. Neurol., 127, 23, 10.1006/exnr.1994.1076

Yan, 1997, Immunocytochemical localization of trkB in the central nervous system of the adult rat, J. Comp. Neurol., 378, 135, 10.1002/(SICI)1096-9861(19970203)378:1<135::AID-CNE8>3.0.CO;2-5

Yankner, 1996, Mechanisms of neuronal degeneration in Alzheimer's disease, Neuron, 16, 921, 10.1016/S0896-6273(00)80115-4

Yankner, 1990, Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides, Science, 250, 279, 10.1126/science.2218531

Yao, 2005, Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w, J. Neurosci., 25, 1149, 10.1523/JNEUROSCI.4736-04.2005

Ylinen, 1991, Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path, Neuropeptides, 19, 205, 10.1016/0143-4179(91)90120-8